Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
763 studies found for:    "Tuberculosis"
Show Display Options
Rank Status Study
1 Completed Tuberculosis Immunity in Children
Condition: Tuberculosis
Intervention:
2 Completed
Has Results
Tuberculosis Treatment Shortening Trial
Condition: Tuberculosis
Interventions: Drug: Pyrazinamide;   Drug: Rifampin;   Drug: Isoniazid;   Drug: Ethambutol
3 Completed Evaluation of a LAM FLISA for the Diagnosis of Tuberculosis
Condition: Tuberculosis
Intervention:
4 Completed Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia
Condition: Tuberculosis
Intervention: Drug: moxifloxacin
5 Unknown  Diagnosis of Active Tuberculosis by ELISPOT
Condition: Tuberculosis
Intervention:
6 Completed Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants
Condition: Tuberculosis
Interventions: Biological: GSK's investigational vaccine 692342;   Biological: Tritanrix™ HB+Hib;   Biological: Prevnar™;   Biological: Polio Sabin™;   Biological: Menjugate™
7 Completed Determining the Impact of Enhanced Case Finding on Tuberculosis Notification in The Gambia
Condition: Tuberculosis
Intervention: Behavioral: Behavioral: community sensitization
8 Completed The Role of Routine Bacterial Culture Including Tuberculosis During Bronchoscopy: A Prospective Study
Condition: Tuberculosis
Intervention:
9 Unknown  Rapid Diagnosis of Pulmonary Tuberculosis
Condition: Tuberculosis
Interventions: Drug: Salbutamol;   Drug: Sodium chloride 5%
10 Terminated Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis
Condition: Tuberculosis
Interventions: Dietary Supplement: Multivitamin supplement containing vitamins B, C, and E;   Drug: Placebo
11 Completed The Role of High Resolution-Computed Tomography (CT) in Tuberculosis (TB) Outbreak Investigation
Condition: Tuberculosis
Intervention:
12 Completed TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
Condition: Tuberculosis
Intervention: Drug: TMC207
13 Recruiting Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection
Condition: Tuberculosis
Intervention: Device: CST001
14 Completed Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination
Condition: Tuberculosis
Interventions: Biological: BCG;   Drug: Isoniazid
15 Unknown  Spatial Epidemiology of Tuberculosis (TB) Infection
Condition: Tuberculosis
Intervention:
16 Completed Treatment Duration for Abdominal Tuberculosis
Condition: Tuberculosis
Interventions: Drug: RNTCP Category I treatment for 6 months;   Drug: RNTCP Category I treatment for 9months
17 Unknown  Follow up of Autoantibodies in Active Tuberculosis
Condition: Tuberculosis
Intervention:
18 Completed
Has Results
Study of Daily Rifapentine for Pulmonary Tuberculosis
Condition: Tuberculosis
Interventions: Drug: Rifapentine;   Drug: Rifampin
19 Recruiting Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection
Condition: Tuberculosis
Intervention: Procedure: blood test, not yet marketed, no trade name
20 Terminated Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease
Condition: Tuberculosis
Interventions: Biological: GSK Biologicals' investigational TB vaccine GSK 692342;   Biological: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.